News | Artificial Intelligence | April 26, 2023

Ascend Cardiovascular Announces Partnership with Us2.ai to Bring an AI-assisted Echocardiography Integration to Cardiovascular Workflow

When integrated with InView, Ascend’s high-performance zero-footprint Cardiovascular viewer, Us2.ai’s FDA-cleared and CE Marked echocardiogram algorithms automate measurements and pre-populate structured report templates.

April 26, 2023 —Ascend Cardiovascular, a leader in cardiovascular structured reporting and workflow solutions is partnering with Us2.ai to add fully automated echocardiography analysis and CV disease detection reporting to its suite of seamlessly integrated cardiovascular image visualization and reporting solutions. 

When integrated with InView, Ascend’s high-performance zero-footprint Cardiovascular viewer, Us2.ai’s FDA-cleared and CE Marked echocardiogram algorithms automate measurements and pre-populate structured report templates. This transforms every day reading and reporting workflow by eliminating manual steps and improving the speed of coordination-of-care for patients with suspected heart disease, the leading cause of death worldwide. 

Ascend InView provides a highly effective, streamlined solution for echo, vascular, and cath viewing and reporting. Using Artificial Intelligence and Machine Learning technologies, InView’s Categorized Hanging Image Protocol (CHIP) analyzes and classifies images by modality and view to automatically organize current and prior images by anatomy and pathology categories. Added value is provided by synchronized navigation and population of structured reports, enabling a streamlined, smart, and highly effective workflow for echo reading and reporting. 

Us2.ai’s technology is a patented, automated clinical decision support workflow solution that recognizes and analyzes 2D and Doppler echo images for comprehensive cardiac measurements needed for the diagnosis, detection and prognosis of heart disease and pulmonary hypertension. Us2.ai’s software decreases the time from patient assessment to treatment initiation by expediting echocardiogram reporting and time-critical diagnostics in the acute and post-acute care phases. “This integration with Ascend brings a reliable and cost-efficient solution to cardiovascular care providers and patients that will drive efficiency, reduce costs, and ultimately improve patient care”, commented Seth Koeppel, Head of Business Development at Us2.ai. 

“The combination of Ascend’s AI-based image review and robust structured reporting with Us2.ai’s automated image analysis and interpretation truly transforms Cardiovascular workflow, making it more effective, efficient, and less variable than traditional, manual alternatives” says Dr. Jeff Soble, practicing Cardiologist and CEO of Ascend Cardiovascular. “This first-of-its kind integration demonstrates Ascend’s commitment to helping the provider community improve Cardiovascular care with complete workflow solutions”.  

For more information: www.ascendcv.com 


Related Content

News | Artificial Intelligence

April 23, 2024 — A recent study designed and implemented by investigators at Cedars-Sinai found that artificial ...

Home April 23, 2024
Home
News | Artificial Intelligence

April 18, 2024 — Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published ...

Home April 18, 2024
Home
News | Artificial Intelligence

April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more ...

Home April 06, 2024
Home
News | Artificial Intelligence

March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...

Home March 28, 2024
Home
News | Artificial Intelligence

March 27 2024 — HeartFlow, Inc., a leader in AI-driven healthcare technology, announced the launch of the DECIDE ...

Home March 27, 2024
Home
News | Artificial Intelligence

March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence (AI)-enabled ...

Home March 07, 2024
Home
News | Artificial Intelligence

March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict ...

Home March 01, 2024
Home
News | Artificial Intelligence

February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges ...

Home February 28, 2024
Home
News | Artificial Intelligence

February 23, 2024 — Cleerly, the company creating a new standard of care to aid in the diagnosis of heart disease ...

Home February 23, 2024
Home
Subscribe Now